课题基金 / 基金详情

CLINICAL CORE

CLINICAL CORE
临床核心
批准号:
7494082
负责人:
HARVEY Ira PASS
金额:
$10.71万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AdultAirAliquotAntibioticsAntibodiesAppendixAsbestosBackBedsBenignBindingBiologicalBiological PreservationBiopsyBiopsy SpecimenBlast CellBuffersCarbonCarbon DioxideCell FractionCell LineCellsCentrifugationChest TubesChloroformChromosomes, Human, Pair 8ClinicalClinical DataCollectionConditionCongestive Heart FailureCore BiopsyCountCountryCulture MediaCultured CellsDNADNA SequenceDataDate of birthDecontaminationDetectionDiagnosisDigestionDiseaseDrug or chemical Tissue DistributionDry IceElectron MicroscopeElectronsEndopeptidase KEngineeringEpidemiologic StudiesEquipmentEthanolEventExcisionFacility Construction Funding CategoryFiberFibers, AFilmFreezingFresh TissueGelGenderGenerationsGenesGenomeGenomicsGoldGrowthHamstersHandHematoxylin and Eosin Staining MethodHomidium BromideHospitalsHourHousingHumanHuman GenomeIndividualInformed ConsentInstitutesInvestigationLaboratoriesLightLiquid substanceLungLung noduleMalignant - descriptorMalignant Mesothelial CellMalignant NeoplasmsMalignant mesotheliomaMalignant neoplasm of lungMesothelial CellMesotheliomaMesotheliumMethodologyMicroscopicMineral FibersMinorityMolecularMolecular WeightMorphologyMutateNatureNeedlesNitrogenNon-MalignantNormal tissue morphologyNucleic Acid Regulatory SequencesNucleic AcidsNumbersOperating RoomsOperative Surgical ProceduresOxygenPO-1ParaffinParaffin EmbeddingPathologicPathologyPatientsPerformancePeritoneumPhenolsPlasmaPlasmid Cloning VectorPlasmidsPlayPleuraPleuralPleural effusion disorderPolymerase Chain ReactionPolyomavirusPopulationPotassium HydroxideProceduresPurposeRNARaceReactionReadingReagentRecommendationRecording of previous eventsRecoveryReplication OriginResearchResearch PersonnelResourcesRiskRoleSamplingSepharoseSerumServicesShippingShipsShoesSideSimian virus 40SiteSlideSourceSouthern BlottingSpecimenStagingStaining methodStainsStandards of Weights and MeasuresStructure of parenchyma of lungSurfaceTechniquesTestingThoracic OncologyThoracotomyTimeTissue BanksTissue MicroarrayTissue SampleTissuesTransmission Electron MicroscopyTrypsinTubeTumor Cell LineTumor TissueValidationVariantVeterans HospitalsVial deviceViralVirusWaterWeekWeightWorkabstractingammonium acetateanticancer researchaqueousbasebeta Globincalretinincancer carecancer cellcarcinogenesiscohortdaydesigneffusionfeedingflasksfootisopentyl alcoholneoplastic celloutreachparticleplanetary Atmospherepreventprogramsresearch facilityresponsesenescencetissue culturetumortumorigenesis

项目摘要

项目成果

HARVEY Ira PASS的其他基金

相似基金

相关文献

中文摘要
翻译
位于Karmanos癌症研究所的临床核心旨在成为该计划的资源 项目作为一个整体,并作为一个有价值的生物材料来源, 个别项目。临床中心将负责收集、储存和分发 间皮瘤细胞和组织以及间皮瘤肿瘤。临床中心的职能是 作为快速冷冻和石蜡包埋的间皮瘤肿瘤组织的资源, 暴露于石棉的胸膜、肺或腹膜,快速冷冻或石蜡包埋。核心 也将作为一个资源,已经建立间皮瘤细胞系,以及正在进行的来源, Karmanos癌症研究所的患者培养的人类间皮细胞。新间皮瘤细胞 将从切除的间皮瘤患者前瞻性地开始。核心将负责 用于确定这些人间皮瘤组织、间皮瘤细胞、间皮瘤 肿瘤和培养的间皮瘤细胞系,以便为研究者提供适当的试剂。 用于免疫组织化学数据验证的组织阵列将由石蜡包埋的肿瘤构建 并提供给个体研究者。临床核心还将协调以下方面的绩效: 间皮瘤患者肺石棉含量分析,以获得个体项目中的相关数据。 据估计,60-80新的间皮瘤病例,每年将看到在Karmanos癌症研究所 在计划项目的过程中,保守估计,其中20-30个将是 作为新鲜/冷冻标本累积。石蜡包埋的肿瘤将从所有病例中获得。肿瘤 样品将用于项目1和3,细胞系/培养物将用于项目2和3。通过 将这些服务集中到一个核心中,收集、存储、分析和分发与 间皮瘤癌变将得到更好的管理和协调整个计划项目。
英文摘要
The Clinical Core housed at the Karmanos Cancer Institute is intended to be a resource for the program project as a whole and as a valuable source of biological materials necessary for the completion of the individual projects. The Clinical Core will be responsible for the collection, storage, and distribution of mesothelial cells and tissues, and mesothelioma tumors. The functions of the Clinical Core will be to serve as a resource for mesothelioma tumor tissue both snap frozen and paraffin embedded, and as a resource for asbestos-exposed pleura, lung, or peritoneum which is either snap frozen or paraffin embedded. The CORE will also serve as a resource for already established mesothelioma cell lines as well as an ongoing source of cultured human mesothelial cells from patients at the Karmanos Cancer Institute. New mesothelioma cell lines will be started prospectively from mesothleioma patients having resection. The Core will be responsible for the determining the SV40 status on these human mesothelial tissues, mesothelial cells, mesothelioma tumors and cultured mesothelioma cell lines in order to provide the appropriate reagents to the investigators. Tissue arrays for immunohistochemical validation of data will be constructed from paraffin embedded tumors and provided to the individual investigators. The Clinical Core will also coordinate the performance of asbestos lung content analysis from patients with mesothelioma for correlative data in the individual projects. It is estimated that 60-80 new mesothelioma cases per year will be seen at the Karmanos Cancer Institute during the course of the program project, and it is conservatively estimated that 20-30 of these will be accrued as fresh/frozen specimens. Paraffin embedded tumors will be available from all cases. Tumor samples will be used in Projects 1 and 3, and cell lines/cultures will be used in projects 2 and 3. By centralizing these services into a Core, the collection, storage, analysis, and distribution of tissues relevant to mesothelioma carcinogenesis will be better managed and coordinated for the entire Program Project.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Microbial and host biomarker development for detection and prognosis of early stage non-small cell lung cancer
The EDRN Mesothelioma Biomarker Discovery Laboratory
The EDRN Mesothelioma Biomarker Discovery Laboratory
The EDRN Mesothelioma Biomarker Discovery Laboratory
国内基金
海外基金
湍流和化学交互作用对H2-Air-H2O微混燃烧中NO生成的影响研究
  • 批准号:
    51976048
  • 项目类别:
    面上项目
  • 资助金额:
    61.0万元
  • 批准年份:
    2019
  • 负责人:
    邱朋华
  • 依托单位: